You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Serine/threonine specific protein kinase inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in San Antonio, Tyler, Spokane (TU2218 + Pembrolizumab)

Recruiting
  • Solid Tumor
  • TU2218 + Pembrolizumab
  • San Antonio, Texas
  • +2 more
Mar 26, 2023

Breast Cancer Trial (GSK3326595)

Completed
  • Breast Cancer
  • London, Ontario, Canada
    St. Joseph's Health Care London
Oct 24, 2022

NSCLC Trial in Worldwide (Sotorasib)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Birmingham, Alabama
  • +65 more
Nov 29, 2022

Solid and Hematological Malignancies Trial in Berlin (Capivasertib, Rabeprazole)

Completed
  • Solid and Hematological Malignancies
  • Berlin, Germany
    Research Site
May 6, 2022

Cancer (With or Without Metastasis) Trial in Houston (TSN084)

Recruiting
  • Cancer (With or Without Metastasis)
  • Houston, Texas
    MD Anderson Cancer Center
Apr 22, 2022

BRAF V600E, Metastatic Colorectal Cancer Trial in China (Encorafenib, Cetuximab, FOLFIRI)

Recruiting
  • BRAF V600E
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
  • +33 more
Dec 20, 2022

NSCLC Trial in China (JAB 21822)

Recruiting
  • Non-small Cell Lung Cancer
  • JAB 21822
  • Beijing, Beijing, China
  • +20 more
Sep 26, 2022

Advanced Solid Tumours Trial in Beijing (Ceralasertib, Durvalumab)

Not yet recruiting
  • Advanced Solid Tumours
  • Beijing, China
    Research Site
Aug 23, 2022

Advanced Solid Tumors Trial in United States (TP-0184)

Completed
  • Advanced Solid Tumors
  • Scottsdale, Arizona
  • +4 more
Apr 4, 2022

Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma Trial in United States

Active, not recruiting
  • Stage III Cutaneous Melanoma AJCC v7
  • +2 more
  • Computed Tomography
  • +3 more
  • Birmingham, Alabama
  • +759 more
Aug 18, 2022

Cancer Trial in Cambridge (AZD6738, Gemcitabine)

Recruiting
  • Cancer
  • Cambridge, England, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Jun 3, 2021

Hypertension Trial in Lancaster (Salt loading, Hydrochlorothiazide (HCTZ))

Completed
Has Results
  • Hypertension
  • Salt loading
  • Hydrochlorothiazide (HCTZ)
  • Lancaster, Pennsylvania
    Amish Research Clinics
Mar 23, 2022

BRAF V600E Unresectable or Metastatic Melanoma, BRAF V600E Metastatic NSCLC, Melanoma Trial in Guangzhou (Encorafenib)

Completed
  • BRAF V600E Unresectable or Metastatic Melanoma
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 9, 2022

Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • B-Cell Lymphoproliferative Disorder
  • Boston, Massachusetts
  • +2 more
Feb 18, 2023

Resistance-associated Mutations in Metastatic Lung Cancer

Recruiting
  • Lung Cancer
  • Liquid biopsy
  • Monza, MB, Italy
    Fondazione IRCCS San Gerardo dei Tintori
Oct 10, 2023

Healthy Volunteers Trial in Rennes (ANT3310, ANT3310-, Meropenem)

Recruiting
  • Healthy Volunteers
  • Rennes, France
    Biotrial
Jun 13, 2023

Toxicity, Healthy Trial in Melbourne (GFH312, Placebo)

Recruiting
  • Toxicity
  • Healthy
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Jan 18, 2022

Advanced Solid Tumor, Advanced or Metastatic NSCLC Trial in Guanzhou, Chengdu (BBP-398)

Recruiting
  • Advanced Solid Tumor
  • Advanced or Metastatic Non-small Cell Lung Cancer
  • Guanzhou, Guangdong, China
  • +1 more
Nov 30, 2022

NSCLC Trial (Bemcentinib, Pembrolizumab, Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Jul 19, 2022

Head and Neck Squamous Cell Carcinoma Trial in France, Taiwan, United States (Ceralasertib, Olaparib)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Pittsburgh, Pennsylvania
  • +3 more
Aug 9, 2021

Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)

Active, not recruiting
  • Low-grade Glioma
  • +2 more
  • Calgary, Alberta, Canada
  • +6 more
Oct 25, 2022

Neurofibromatosis 1, Neurofibroma Plexiform Trial in Shanghai (Selumetinib)

Active, not recruiting
  • Neurofibromatosis 1
  • Neurofibroma Plexiform
  • Shanghai, China
  • +1 more
Jan 13, 2023

Interleukin and Autoantibodies in Myasthenia Gravis.

Not yet recruiting
  • Myasthenia Gravis
  • real time PCR , ELISA
  • (no location specified)
Apr 27, 2022

Diabetes, Type 2 Trial in Tanta, Shibin Al Kawm (Ursodeoxycholic acid)

Recruiting
  • Diabetes Mellitus, Type 2
  • Ursodeoxycholic acid
  • Tanta, El-Gharbia, Egypt
  • +1 more
Jun 5, 2023

Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)

Recruiting
  • Leukemia, Monocytic, Acute
  • Pediatric AML
  • Foshan, Guangdong, China
  • +8 more
Mar 28, 2022